Phospho-TAK1 (Thr187) Recombinant antibody
Phospho-TAK1 (Thr187) Recombinant Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
Human
Applications
WB, ELISA
Conjugate
Unconjugated
CloneNo.
2O6
Cat no : 81785-1-RR
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | Calyculin A treated HEK-293 cells, Calyculin A treated HeLa cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:20000-1:100000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
81785-1-RR targets Phospho-TAK1 (Thr187) in WB, ELISA applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | Peptide 相同性解析による交差性が予測される生物種 |
Full Name | mitogen-activated protein kinase kinase kinase 7 |
Calculated molecular weight | 579 aa, 64 kDa |
Observed molecular weight | 75-85 kDa |
GenBank accession number | BC017715 |
Gene symbol | TAK1 |
Gene ID (NCBI) | 6885 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
MAP3K7(Mitogen-activated protein kinase kinase kinase 7) is also named TAK1 and belongs to the MAP kinase kinase kinase subfamily. It plays an important role in the cascades of cellular responses evoked by changes in the environment. It has been linked to interleukin-1 receptor and tumor necrosis factor receptor signaling (PMID: 16186825). It has 4 isoforms (53-55 kDa; 64-70 kDa and 75-80 kDa)produced by alternative splicing.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for Phospho-TAK1 (Thr187) antibody 81785-1-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |